While it is evident that the carboxylterminal region of natural peptide ligands bind to the amino-terminal domain of class B GPCRs, how their biologically critical amino-terminal regions dock to the receptor is unclear. We utilize cysteine trapping to systematically explore spatial approximations among residues in the first five positions of secretin and in every position within the receptor extracellular loops (ECLs The secretin receptor belongs to the class B family of peptide-binding G-protein-coupled receptors (GPCRs) that consists of many important drug targets, including receptors for secretin, vasoactive intestinal polypeptide (VIP), pituitary adenylate cyclase-activating peptide (PACAP), glucagon-like peptide-1 (GLP-1), glucosedependent insulinotropic peptide (GIP), glucagon, calcitonin, parathyroid hormone (PTH), and corticotrophin-releasing factor (CRF) (1). The molecular basis of natural ligand binding and activation of these receptors are less well understood than for class A GPCRs, where a growing number of high-resolution structures are available (2).
docking the biologically critical amino-terminal regions of these ligands to their intact receptors is less clearly understood.
Photoaffinity labeling is a powerful approach for direct mapping of molecular approximations between residues within a ligand and its receptor that has been applied to many GPCRs, including members of the class B family (3, 5) . Previously, we used this approach to define spatial approximations between residues within the amino-terminal region of secretin [benzoylphenylalanines (Bpa) in positions of His 1 and Thr 5 ] and those within the core domain of its intact receptor [Phe 338 at the top of transmembrane (TM) segment 6 (TM6) and Phe 349 in extracellular loop 3 (ECL3) of the rat secretin receptor, respectively] (6, 7). These constraints have been used to guide docking of the secretin amino terminus to its intact receptor during efforts to build meaningful 3-dimensional molecular models (6, 7) . However, given the large size and hydrophobicity of the photolabile Bpa moiety incorporated into these secretin probes, they can provide only low-resolution spatial constraints for modeling of the secretin-occupied receptor.
We now use the cysteine-trapping approach (8 -11) to explore spatial approximations between cysteine residues incorporated into the amino-terminal region of secretin docked at its receptor and cysteines in every position within each of the receptor extracellular loops (ECLs) and to thereby collect a broad survey of welldefined, spatially directed constraints. This reflects the small size of the cysteine residues and the short lengths and well-defined geometry of the disulfide bonds formed in this approach. Of the probes incorporating a cysteine into each of 5 amino-terminal positions within secretin that are distal to the helix N-capping motif (12) , only the position 2 and 5 probes retained full biological activity and sufficient binding affinity for further study. These were used to probe 61 cysteinereplacement mutants representing every position along each of the ECLs, as well as positions high in likely TM segments; 47 of these mutants exhibited adequate density of cell surface expression and adequate affinity to provide meaningful covalent labeling data. Because of variability in levels of these parameters, both affecting numbers of receptors occupied and available for covalent labeling, the covalent labeling efficiency data were considered for these positions only and were interpreted qualitatively, with those having apparent efficiencies Ͼ50% utilized for constraining the evolving molecular models.
Here, we report the differential patterns of disulfide formation by these two probes, providing insights useful for further understanding the mechanisms of ligand binding and activation of not only the secretin receptor but also other class B GPCRs. These distance constraints have been utilized to refine our understanding of the structure of the secretin ligand-receptor complex and to provide new and important insights into the orientation of the major receptor domains, and into the conformation of the ECL regions, which have heretofore been relatively unconstrained experimentally. The multiplicity of labeled residues also provides insights into the dynamic process of ligand binding to its receptor that is absent from photoaffinity labeling of a stable complex and from NMR and crystal structures. The positive and negative data representing the spectrum of receptor residues that can and cannot establish disulfide bonds in this approach provide valuable insights into the fluidity of the docking process and the conformational space being sampled.
MATERIALS AND METHODS

Peptides
Five peptides were prepared, representing analogues of human secretin (Fig. 1) . Replacement of the leucine naturally present in position 10 with a radioiodinatable tyrosine has previously been demonstrated to be compatible with normal peptide binding and biological activity (13) . All peptides were synthesized by manual solidphase techniques using Pal resin and purified by reversed-phase HPLC, as described previously (14) . The expected molecular masses of the peptides were verified by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Cys ]secretin were radioiodinated oxidatively as described previously (3).
Receptor constructs
A Chinese hamster ovary (CHO) cell line stably expressing the wild-type (WT) human secretin receptor (CHO-SecR; ref. 15 ) was used as a source of receptor for characterizing the binding affinities and biological activities of the cysteinecontaining secretin analogues in the current study. Cells were cultured at 37°C in an environment containing 5% CO 2 on tissue culture plasticware in Ham's F-12 medium supplemented with 5% fetal clone II (Hyclone laboratories, Logan, UT, USA), and were passaged ϳ2ϫ/wk.
The cysteine-containing secretin analogues found to have full biological activities and adequate binding affinities were further studied using a broad variety of mutant secretin receptor constructs (and WT receptor) as transiently expressed in COS-1 cells (American Type Culture Collection, Manassas, VA, USA). A total of 61 secretin receptor constructs incorporating cysteine replacements for natural residues in each of the positions of the 3 ECLs were generated ( Table 1) . We also prepared three alanine replacement mutants for ECL2 residues that were predicted in the current study to interact with the amino-terminal residues His 1 , Asp
3
, and Gly 4 of secretin (W274A, N268A and F258A), and a construct replacing the Phe residue in position 258 with a Trp (F258W). All these constructs were prepared using the QuikChange Site-directed Mutagenesis kit from Stratagene (La Jolla, CA, USA) and using WT human secretin receptor in the pcDNA3.1 vector as the template, with the products verified by direct DNA sequencing. These secretin receptor constructs were expressed transiently in COS-1 cells using a modification of the DEAE-dextran protocol that included dimethyl sulfoxide shock and treatment with chloroquine diphosphate (16) . They were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA, USA) supplemented with 5% fetal clone II. Cells were studied 48 h after transfection.
Receptor binding and biological activity assays
A well-established receptor binding assay (3) was used to determine the ability of each of the 5 cysteine-containing secretin analogues to compete for secretin radioligand binding to intact CHO-SecR cells, as well as to characterize the binding affinities of the Cys 2 -sec and Cys 5 -sec probes at each of the secretin receptor cysteine-or alanine-replacement constructs expressed in COS-1 cells. A cAMP assay was used to examine the ability of the cysteine-containing secretin analogues to stimulate cAMP responses in CHO-SecR cells and the ability of natural secretin to stimulate cAMP responses in COS-1 cells expressing each of the secretin receptor cysteineor alanine-replacement constructs as we have described (3). Competition-binding and cAMP concentration-response curves were analyzed and plotted using the nonlinear regression analysis program in the Prism 3.0 software suite (GraphPad, San Diego, CA, USA). Binding kinetics were determined by analysis with the LIGAND program of Munson and Rodbard (17) .
Cell surface expression assay
Flow cytometry using an amino-terminal region secretin receptor antibody (18) was performed in transfected COS-1 cells to determine levels of cell surface expression of the constructs that did not exhibit saturable binding of secretin. This was performed using a CyAn ADP Flow Cytometer (DakoCytomation, Carpinteria, CA, USA) and analyzed using FlowJo 7.6 software (TreeStar, Ashland, OR, USA).
Cysteine trapping
COS-1 cells were seeded in 24-well plates and grown to ϳ80% confluence prior to transfection. Medium was removed and replaced with 1 ml DMEM with 5% fetal clone II. For each well, 200 l DNA/polyethylenimine mixture in serum-free DMEM containing 0.5 g DNA (WT or cysteine-containing secretin receptor constructs) and 37.5 g/ml polyethylenimine (25 kDa linear; Polysciences, Warrington, PA, USA) were mixed and incubated for 15 min at room temperature before being added to the cells. On the day after transfection, 1 ml DMEM with 5% fetal clone II was added to the cells. After culture for another 48 h, cells were washed once, and 200 l 125 I-Cys 2 -sec or 125 I-Cys 5 -sec (ϳ100,000 cpm) in DMEM containing 5% fetal clone II was added. After incubation for 1.5 h at room temperature, medium was aspirated, and cells were washed once with ice-cold PBS before 80 l SDS Laemmli sample buffer (19) with or without 0.1 M dithiothreitol (DTT) was added to each well. After incubation for 45 min, cells were scraped from the wells and lysates were transferred to 1.5 ml microcentrifuge tubes. After sonication using a Branson Sonifier microtip (G. Heinemann, Schwäbish Gmünd, Germany) for 5 s, samples were resolved in a 10% SDS-polyacrylamide gel. The gel was dried, and bands of interest were visualized by autoradiography with band densitometry analyzed by ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA). The apparent molecular weights of the radioactive bands were determined by interpolation on a plot of the mobility of the appropriate ProSieve protein markers (Cambrex, Rockland, ME, USA) vs. the log values of their apparent masses. Lengths of exposure of the autoradiographs varied, based on the band intensities. Some conditions yielded no specifically labeled bands, even after 8-to 9-d exposures, representing more than twice the typical exposure time of the gels yielding specific covalent labeling. All of the labeling reactions with a single probe were normalized in experiments in which several of the dominantly labeled bands from each ECL region were again labeled with the same radioligand and run on a single gel that was exposed for the optimal period of time to allow quantitation and extrapolation of the labeling efficiency of all of the other constructs.
Molecular modeling
All molecular modeling was conducted using a stochastic global energy optimization procedure in Internal Coordinate Mechanics (ICM; ref. 20) with the ICM-Pro 3.7 package (MolSoft LLC, San Diego, CA, USA) using the procedure we have previously described (3). The initial model of the amino-terminal domain of the human secretin receptor was generated using the X-ray structure of the amino terminus of the GIP receptor complexed with the GIP peptide [Protein Data Bank (PDB) code: 2QKH; ref. 21] as template. As the structure for this template terminates near the third disulfide bond (Cys 67 -Cys 101 ), we extended an ␣-helical structure to the top of the first TM segment (TM1) based on the secondary structure prediction algorithms in ICM that suggest the propensity for ␣-helical conformation in this region of the family B GPCRs. A pentasaccharide Man 3 GlcNAc 2 was attached to secretin receptor residues Asn 51 , Asn 79 , Asn 85 , and Asn 107 to mimic their glycosylated state. The initial conformation of the human secretin peptide was generated using the NMR structure of receptor-bound PACAP(1-21)NH 2 as template, and aligning this with GIP in the GIP/GIP receptor complex to determine its initial docking pose. The initial pose did not satisfy all experimentally determined photoaffinity labeling constraints. The whole complex was, therefore, globally optimized in the presence of the following spatial approximation constraints coming from photoaffinity labeling experiments in the rat secretin receptor (3) (22) were also incorporated. The backbone dihedral around the first (Cys 24 -Cys 54 ) and last (Cys 68 -Cys 102 ) disulfide bond of the amino-terminal domain were relaxed to allow for rotational freedom, resulting in a better fit of the experimental constraint data. A total of 25 of the lowest energy complexes were retained.
The TM bundle was constructed using the X-ray structure of CXCR4 (PDB code: 3ODU) as template (23 . We attempted multiple alternative alignments of TM4, TM5, TM6, and TM7 in light of the current data. The best model was obtained when TM4, TM5, and TM7 were shifted upward toward the extracellular side by 4 residues relative to the previous model, while the alignment of TM6 remained unaltered. ). All the resultant models were clustered, ranked by their ICM energetics and their health as established by PROCHECK and WHAT_CHECK evaluations (24) . The best model from 200 independent runs was selected.
RESULTS
Functional characterization of cysteine-containing probes
Each of the 5 cysteine-containing secretin analogues was characterized to determine its ability to bind to secretin receptor-bearing CHO-SecR cells and to stimulate intracellular cAMP accumulation in these cells. Only Cys 5 -sec and Cys 2 -sec peptides bound to the secretin receptor with submicromolar affinities (IC 50 : secretin, 0.3Ϯ0.02 nM; Cys 5 -sec, 83Ϯ1 nM; Cys 2 -sec, 92Ϯ4 nM; Fig. 1 ). These peptides were fully efficacious agonists, capable of stimulating cAMP responses similar to those elicited by natural secretin, although their potencies were lower than that of secretin. Cys 5 -sec was much more potent than Cys 2 -sec (EC 50 : secretin, 8Ϯ2 pM; Cys 5 -sec, 124Ϯ22 pM; Cys 2 -sec, 9521Ϯ955 pM). While the other four cysteine-containing secretin analogues bound to the secretin receptor with affinities too low to demonstrate directly in radioligand binding studies, they were fully efficacious agonists that could stimulate full cAMP responses in intact cells when used in high concentrations (Fig. 1) . The maximal cAMP response values were 220 Ϯ 10, 210 Ϯ 9, and 224 Ϯ 18 pmol/10 6 cells for secretin, Cys 5 -sec, and Cys 2 -sec, respectively. It is important to note that the intrinsic efficacies of these full agonists were different from each other. Natural secretin stimulated a half-maximal cAMP response when it occupied 3% of the receptors (IC 50 / EC 50 ϫ 100), while Cys 5 -sec stimulated a similar response with Ͻ1% of the receptors occupied, and Cys 2 -sec stimulated the same response with 10% of the receptors occupied. Values represent means Ϯ se of Ն3 independent assays performed in duplicate. Two-tailed t tests were performed to determine the significance of differences using InStat3 (GraphPad, San Diego, CA, USA). ND, not detectable. *P Ͻ 0.05, **P Ͻ 0.01 vs. WT receptor. 
Functional characterization of cysteine-containing secretin receptor constructs
Each of the cysteine-containing secretin receptor constructs was expressed in COS-1 cells and characterized in radioligand binding and biological activity assays ( Table 1) . Most of the constructs had binding affinities within 10-fold that of the WT secretin receptor. Only 14 constructs (11 in ECL1 and 3 in ECL2) exhibited no saturable binding, although all but one of these (W265C) had full cAMP responses to secretin. Flow cytometric analysis confirmed that these constructs had similar levels of cell surface expression of immunoreactive receptor to that of WT secretin receptor (Fig. 2) .
Cysteine-trapping studies Figure 3 illustrates representative autoradiographs of nonreduced and reduced gels in which each probe was utilized with WT receptor and with each of the cysteinereplacement mutants scanning each of the ECLs. Wildtype secretin receptor was not covalently labeled (disulfide bond formed) by either Cys 5 -sec or Cys 2 -sec probe, providing important negative controls. Densitometric quatitation of the receptor labeling in the absence of reduction is shown in Table 2 . The patterns of disulfide bond formation for each of the probes and their relative efficiencies of labeling were quite distinct. Despite prolonged exposures of the autoradiographs, no labeling was observed with any of these mutants in the presence of DTT or in the presence of 1 M secretin, a competition control.
Molecular modeling
The distance constraints obtained from photoaffinity labeling and FRET studies in the rat secretin receptor were applied to the human secretin receptor to begin to develop the new model. Eight restraints were imposed on this model, representing distance constraints linking the pairs of cysteine residues that were most efficiently and selectively disulfide-bonded with the Cys ). However, inspection of the initial model generated by threading the human sequence to the previous rat secretin receptor model suggested that the previous alignment of the TM domain was inadequate to satisfy the current experimental constraints. Due to the low sequence homology between class A and class B GPCRs, the cold-spot method we previously employed, in which the conserved residues in class B receptors were aligned with those of class A receptors, did not provide an adequately precise alignment. The pattern of conserved residues could still be maintained by shifting the TM helices upward or downward by one or even multiple helical turns. We explored different alignments within the TM domain, and the best model was obtained by shifting the TM4, TM5, TM7 segments upward by 4 residues-roughly one helical turn. This helped to produce a molecular model that satisfied all of the relevant experimentally derived constraints. This new molecular model is shown in Fig. 4 . The C ␤ -C ␤ distances between the Cys probes and the residues they labeled in this model are shown in Table 3 .
Functional characterization of selected receptor mutants to test molecular model
Inspection of the best molecular model of the secretinoccupied secretin receptor provided some possible explanations for the functional importance of secretin residues 1, 3, and 4, positions in which incorporating a cysteine residue resulted in very low binding affinity. The functional importance of these residues was also clearly demonstrated in our previous alanine scanning studies of secretin (25) . Possible spatial approximations between these ligand residues and those of the receptor are highlighted in Fig. 5, illustrating Figure 6 shows that replacement of each of these receptor residues with an alanine indeed resulted in decreased secretin binding affinity (K i : WT, 0.6Ϯ0.1 nM; W274A, 5.7Ϯ1.0 nM; N268A, 1.7Ϯ0.3 nM; F258A, 3.3Ϯ0.7 nM) and secretin-stimulated biological responses (EC 50 : WT, 45Ϯ11 pM; W274A, 4119Ϯ793 pM; N268A, 371Ϯ153 pM; F258A, 366Ϯ146 pM). The densities of receptors on the surface of these cells were not different for any of the constructs (B max , binding sites per cell: WT, 143,000Ϯ16,000; W274A, 193,000Ϯ15,000; N268A, 113,000Ϯ18,000; F258A, 160,000Ϯ32,000).
These predicted spatial approximations were further tested, attempting to enhance binding affinity and/or biological activity. For the predicted interaction between secretin peptide residue His 1 and receptor residue Trp 274 , both binding affinity (IC 50 : WT, 900Ϯ100 nM; W274C, 75Ϯ20 nM) and biological activity (EC 50 :
of each pair) of reducing agent (DTT). Between the autoradiographs are bar graphs representing the efficiency of labeling of residues within each of the ECL regions as percentages of the band in that ECL with highest labeling intensity using densitometric data from 3 independent cysteine trapping experiments (quantitation in Table 2 ). Since no bands were observed for Cys 5 -sec labeling of ECL1 residues, no densitometry was included. All gels for ECL1 labeling were exposed for autoradiography for 8 -9 d. For ECL2 labeling, the nonreduced gels were exposed for 4 -5 d, and the reduced gels were exposed for 8 d. For ECL3 labeling, the nonreduced gels for Cys 5 -sec labeling were exposed for 3 d, while those for Cys 2 -sec labeling were exposed for 3-4 d, and all the reduced gels were exposed for 8 d. Table 2 also includes overall efficiency of labeling of residues by each of the probes, normalized relative to the labeling intensity of the residue within any of the three loops that was labeled most efficiently. 36 .7Ϯ7.0 nM) had only a small effect on binding affinity and no effect on biological activity (Fig. 7) . For the predicted interaction between peptide residue Asp 3 and receptor residue Asn
268
, both binding affinity (IC 50 : WT, 665Ϯ25 nM; N268C, 20Ϯ10 nM) and biological activity (EC 50 : WT, 21.0Ϯ1.0 nM; N268C, 4.2Ϯ0.9 nM) of Cys 3 -sec were enhanced when replacing this receptor residue with a Cys, while replacing it with an Ala (IC 50 : 527Ϯ153 nM; EC 50 : 22.7Ϯ2.2 nM) had no effect (Fig. 7) . The introduction of a new disulfide bond was not similarly beneficial for the predicted interaction of secretin residue Gly 4 and receptor residue Phe 258 (IC 50 : WT, 675Ϯ165 nM; F258A, 723Ϯ64 nM; F258C, 732Ϯ216 nM; EC 50 : WT, 49.8Ϯ20.8 nM; F258A, 21.3Ϯ6.2 nM; F258C, 24.2Ϯ3.9 nM), perhaps reflecting the requirement for the small Gly in this position (Fig. 7) . To test this predicted interaction with natural secretin further, we prepared the mutant receptor in which Phe 258 was replaced with a Trp, a change predicted in the model to be tolerated and that could possibly even yield an additional hydrogen bond with the docked peptide. Consistent with this, secretin bound to the F258W construct with normal affinity (IC 50 : WT, 1.4Ϯ0.2 nM; F258W, 1.9Ϯ0.4 nM) and had normal potency (EC 50 : WT, 42Ϯ13 pM; F258W, 43Ϯ14 pM) for stimulating a cAMP response (Fig. 6) . Presumably, the addition of a hydrogen bond did not provide enough additional energy to shift the curves, however it is notable that alanine was not tolerated in the same position (F258A), reducing both binding and biological activity.
DISCUSSION
Despite the rapid recent progress in the solution of crystal structures of several class A GPCRs (2), the understanding of the structures of class B GPCRs remains very limited. Only the structures of the aminoterminal domains of several members of class B GPCRs, the predominant site of docking of the carboxyl-terminal region of the natural ligands, have been solved by NMR and/or crystallography (4). However, our understanding of the orientation of this domain relative to the receptor core domain, and even the structures of the helical bundle and ECL regions of these receptors, are poorly understood. In the absence of 3-dimensional conformational models of the intact receptors in this family, insights into the mechanisms of their ligand binding and activation are quite limited, and any ability to rationally design or refine receptor-active drugs based on the current level of understanding is unrealistic.
The current understanding of the molecular basis of docking of the amino-terminal regions of natural peptide ligands of class B GPCRs is based largely on structureactivity considerations using truncated, mutant, and chimeric receptor constructs and peptide-ligand analogues (25, 26) , as well as data from photoaffinity labeling studies (3). These studies have universally supported the importance of core receptor regions for interactions with the amino-terminal region of the natural peptide ligands, the region most critical for biological activity (1) . However, the details have varied somewhat from receptor to receptor, and the level of constraint provided by such studies has not been adequate to refine our understanding of receptor-ligand interaction.
A number of predictions for possible interactions between peptide and receptor and for the docking of the peptides have been made based on the mutagenesis of residues within the amino-terminal region of class B receptor peptides (27) (28) (29) (30) (31) (32) Values represent means Ϯ se of Ն3 independent experiments. Intraloop labeling efficiency represents the intensity of labeling of each band as a percentage of the intensity of the band with the highest labeling intensity within each loop using densitometric analysis. Overall labeling efficiency represents the intensity of labeling of each band as a percentage of the intensity of the band with the highest labeling intensity using that probe in all three loops using densitometric analysis. Underscored values represent constructs with overall intensities Ͼ25%. ND, not detectable.
these other natural ligands, its first two amino-terminal residues have been suggested to interact with residues in TM2, TM5, TM6, ECL3 and TM7 of the PTH1 receptor (30) . Without a clear understanding of the conformations of the loop regions of the receptors in this family and how closely related they might be to each other, these data are difficult to interpret, other than providing evidence that the amino terminus of natural peptide ligands of these receptors are directed toward the receptor core.
Photoaffinity labeling studies have the advantage of being more direct and have contributed more insights into the docking of the amino terminus of class B GPCR peptide ligands. However, the data have been useful only for establishing a general pose for this portion of the ligands, and these data have not been useful in the refinement of the orientation of the major receptor domains or in the refinement of the conformation of the helical bundle or of the ECLs. Here too, there have been experimental differences from receptor to receptor. The amino terminus of secretin is spatially approximated with the top of TM6 of its receptor (incorporation of a photolabile Bpa into position 1 of secretin-labeled rat receptor residue Phe 338 analogous to Phe 339 in the human receptor; ref. 7). However, in analogous studies, the amino terminus of GLP-1 labels a residue within ECL1 of its receptor (5), the amino terminus of VIP labels the hinge region between the amino terminus and TM1 of its receptor (27) , and the amino terminus of CRF1 labels ECL2 of its receptor (34) . Photolabile residues in positions 1 and 2 of PTH label residues in TM6 of the PTH1 and PTH2 receptors (35, 36) . A second spatial approximation constraint for the secretin receptor was experimentally defined using another probe with Bpa in position 5 that labeled Phe 349 within ECL3 (analogous to human receptor residue Phe 350 ; ref. 6 ).
In the current study, we used the independent and complementary approach of cysteine trapping to evaluate the spatial relationship between cysteine residues incorporated into the amino-terminal region of secretin and cysteine residues incorporated to replace each residue spanning all three ECLs of the receptor. In this approach, formation of a covalent disulfide bond requires specific distance (S ␥ -S ␥ distance 2.04Ϯ0.07Å) and geometry (C ␤ -S ␥ -S ␥ -C ␤ dihedral angle 90Ϯ12 o ) (37), thus providing a higher level of selectivity than is present in photoaffinity labeling. Cysteine trapping was previously used to study interactions of small molecules and peptides of the class A complement factor 5a receptor (8 -10), and it was recently applied to a single loop within the class B PTH receptor (11) . It has not previously been applied so broadly to all possible positions within each of the ECLs of a GPCR.
Only two cysteine-containing secretin probes (Cys 2 -sec and Cys 5 -sec) maintained adequate binding affinity and full biological activity, allowing them to be used in a meaningful way in the current studies. These two positions were also the positions in which alanine replacements were best tolerated in a recent report of Modeled secretin receptor (orange ribbon and sticks) and peptide (magenta ribbon) are displayed with the key residues that were labeled by Cys 2 -sec (blue sticks: F258, W274, S340, and P341) and Cys 5 -sec (red sticks: E342, I347, Q348, and F351) probes. Bottom panel: binding pocket. Modeled secretin receptor (orange ribbon and sticks) and peptide (magenta ribbon) are displayed with the pocket surface colored based on its binding properties (white, neutral; green, hydrophobic; red, hydrogen bonding acceptor potential; blue, hydrogen bonding donor potential). alanine-scanning mutagenesis of this hormone (25) . For this experimental approach to be successful, it is also important that no naturally occurring cysteine residues within the receptor be accessible to form disulfide bonds with the cysteine-containing probes. Seven cysteine residues occur naturally in the amino terminus of the WT human secretin receptor (38 -sec nor Cys 2 -sec labeled the WT secretin receptor, supporting the interpretation that neither of these free cysteine residues are in close approximation with the cysteines present in the secretin analog probes as they were docked with this receptor.
Both probes provided exciting new data that was useful to enhance our understanding of peptide docking and of the conformation of previously unconstrained regions of a class B GPCR. One key observation was that each of these probes formed disulfide bonds with an extensive network of receptor residues across multiple loops. This finding is consistent with a highly dynamic and flexible ligand-receptor interface, with the fluid ability to form disulfide bonds as the ligand approaches the receptor and as both undergo conformational changes. This is quite different from the stable pose of the ligand-occupied receptor at the time of photolysis in photoaffinity labeling or of the stable conformation identified in crystal structures. Dynamically mobile and flexible loops are predicted in molecular dynamic simulations of GPCRs and indeed may be required for the entry and egress of small molecule ligands binding to the TM receptor core (39, 40) . Clearly, the biologically active amino terminus of secretin has substantial mobility relative the receptor as it undergoes docking. Although it would have been ideal to effectively , representing the secretin residues within the peptide amino terminus that were shown to be difficult to replace with alanine or cysteine in structure-activity studies. A) Proposed interaction between peptide residue H1 and receptor residue W274 is most compatible with a hydrophobic interaction. B) Proposed interaction between D3 and N268 involves a hydrogen bond (green spheres). B) G4 is proposed to be closest to F258. Other neighboring residues within 5 Å of each peptide residue are also displayed, using thin orange stick. probe every position in every loop region, this was not possible due to the inability to replace every residue with cysteine while maintaining its full function. We could analyze the data from 70% of the cysteinereplacement mutants, in which adequate levels of cell surface expression, secretin binding activity, and secretin-stimulated cAMP responses were demonstrated. Of these, only those mutants having labeling efficiency in the highest 50% were utilized to provide positive constraints for the molecular modeling. The practical utility of this became clear when the resulting enhanced molecular models were tested experimentally.
While the current data with the Cys 5 -sec probe were consistent with the previous photoaffinity labeling data, substantial additional insights were provided by the additional sites of efficient cysteine trapping. While this probe did not label any residues within ECL1, it labeled four residues within ECL2 with efficiency Ͼ25% of the residue most efficiently labeled, with three of these residues in the carboxyl-terminal region of this loop, as well as 10 residues within ECL3, with 7 of these residues having labeling efficiency Ͼ50%. The relative efficiencies in forming these covalent disulfide bonds were useful in providing constraints for spatial approximation, as well as demonstrating which loop residues were accessible to this position within the ligand. The covalent labeling of successive residues within loops 2 and 3 provides evidence for these regions being in an extended conformation rather than an ␣-helical conformation where opposite sites of the helix would not have been accessible to form such bonds.
While the Cys The positions of cysteine residues that were most efficiently trapped by each of these probes were utilized to test and refine our previous molecular model of secretin docked at its receptor, coming from an extensive series of photoaffinity labeling constraints and FRET-derived distances between fluorophores scattered along the ligand and those incorporated into receptor loop regions (3, 22) . To obtain a model closest to the final peptide/ receptor complex, we focused on residues that were labeled with the highest efficiencies, but preferentially labeled one probe over the other. ligand and receptor as new distance restraints also enabled improvement in the modeling of the TM region of the receptor. Previous models utilizing cold-spot alignment of the conserved residues in family B GPCRs to those in family A GPCRs where crystal structures are available were incompatible with the new distance constraints. While the sequence homology between the two families of receptors is limited, the pattern of conserved residues can still be preserved by shifting TM helices upward or downward by one or more helical turns. The current data thus allowed us to refine our TM domain alignment from our previous model: TM4 was shifted upward to accommodate Cys This shift in helix 4 maintained the correct orientation of lipid-facing residues previously identified as being involved in secretin receptor dimerization (41) . The final distance for the last pair of residues remained long for both the final best overall model and for all other models obtained in the iterative process. This seems to indicate that receptor residue 351 could be labeled before the peptide resides in its final bound conformation or that this region of the receptor is still not optimally refined. Unfortunately, no adequate experimental constraints yet exist to rationally better refine this portion of the model.
The refined model presented in the current study provides insights into new testable interactions, particularly those that involve the natural residues that could not be effectively replaced with cysteines for cysteine trapping and that could not be effectively replaced with alanines in our previous scanning study (25) . The histidine in position one is known to be critically important for binding and biological activity (25) . The current model suggests that its closest neighbor, as docked, is Trp 274 at the top of TM5, with this most consistent with a hydrophobic interaction (Fig. 5) . Consistent with such an interaction, replacing secretin residue His 1 with an alanine (25) has been shown to be less well tolerated than replacing it with a Bpa (7). Further, we now show that replacement of receptor residue Trp 274 with an Ala (W274A) resulted in a 10-fold reduction in secretin binding affinity and a 92-fold reduction in secretin-stimulated biological responses (Fig. 6) . In contrast, replacing this residue with a Cys (W274C) provided an acceptor for a new disulfide bond with Cys 1 -sec, enhancing its binding affinity by 12-fold and its biological potency by 4-fold (Fig. 7) .
The current model also suggests that secretin residue Asp 3 is closest to receptor residue Asn 268 in ECL2 (Fig. 5) , with these residues capable of generating a hydrogen bond. Indeed, replacement of Asp 268 with alanine (N268A) resulted in a 3-fold reduction in secretin binding affinity and an 8-fold reduction in its biological activity (Fig. 6 ). This aspartate is also conserved in many class B GPCRs and is critical for binding and biological activity of secretin, VIP, GLP-1, and PACAP (25) . Here, too, replacing this residue with a Cys (N268C) provided an acceptor for a new disulfide bond with Cys 3 -sec, enhancing its binding affinity by 33-fold and its biological potency by 5-fold (Fig. 7) .
The current model additionally suggests that the secretin residue Gly 4 is in close contact with receptor residue Phe 258 at the top of TM4 (Fig. 5) . We also know from structureactivity series that replacing this glycine with alanine (25) and Bpa (data not shown) were poorly tolerated. This finding suggests that residues larger than glycine could sterically hinder docking. Indeed, we now also show that replacing receptor residue Phe 258 with an alanine (F258A) resulted in a 6-fold reduction in secretin binding affinity and an 8-fold reduction in its biological activity (Fig. 6 ). Also consistent with this requirement for a Gly residue was the inability to replace this residue with a Cys (F258C) to directly test its interaction with Cys 4 -sec (Fig. 7) . The molecular model suggested the possibility of adequate space to replace this Phe with a Trp residue, thereby perhaps even leading to an additional hydrogen bond to the docked peptide. Indeed, the F258W mutant was shown to bind secretin with normal affinity and to be stimulated by it with normal potency, unlike the F258A mutant in which both functions were reduced (Fig. 6) . While the F258W mutation was tolerated, it did not yield a demonstrable improvement in binding, likely reflecting the relatively small additional energy such a bond might contribute to the total binding energy of a 27-residue peptide.
Thus, the refined molecular model developed based on extensive systematic cysteine trapping approach enhances our understanding of the molecular conformation of this prototypic class B GPCR and the molecular basis of natural ligand docking, but it also has predictive power for likely interactions between residues in the ligand and in the receptor.
